專題討論-生物科技管理實務

本課程係陽明交通大學與政治大學共同開設之生物科技管理學程的必修課程,針對生物科技產業所需選擇頂尖國際專業期刊的跨領域熱門議題來掌握世界的新趨勢內容包括商業策略、智慧財產、經營能力與管理方法、生物科技通識以及法律及訴訟實例探討等,透過產官學研專家參與討論,腦力激盪 ,培養同學跨領域的學習效果。 提供具備生醫專業背景的學生有相關產業管理能力,也提供文法商背景的學生進入生物科技領域的機會,增加對生物科技的認識與瞭解。

陽明政大跨領域生物科技管理學程專題討論課程 Pan-coronavirus vaccine pipeline takes form. Nature Reviews Drug Discovery, 27:940, 2022 Drug repurposing-An effective strategy to accelerate contemporary drug discovery. Drug Discovery Today27:1785, 2022 ATP as anti-aging agent: beyond the energy reservoir, Drug Discovery Today, 26:2783, 2022 Heart disease after COVID: What the data say. Nature 608:26, 2022. Can preclinical drug development help to predict adverse events in clinical trials. Drug Discovery Today, 27: 257, 2022 Evolution of innovative drug R&D in China. Nature Reviews Drug Discovery, 2022. Harnessing the predictive power of preclinical models for oncology drug development. Nature Reviews Drug Discovery,21:99, 2022 Integrating heterogeneous data to facilitate COVID-19 drug repurposing. Drug Discovery Today, 22:558, 2022. Intranasal vaccines for SARS-CoV-2- From challenges to potential in COVID-19 management. Drug Discovery Today, 26:2619, 2022 Medicinal mushrooms-Clinical perspective. Drug Discovery Today, 27:636, 2022 Targeting oxidative stress in disease- promise and limitations of antioxidant therapy. Nature Reviews Drug Discovery, 20:689, 2021 How much do the public sector and private sector contribute to biopharmaceutical R&D. Drug Discovery Today, 27:939, 2022 Translational misconceptions, Nature Reviews Drug Discovery, 20:489, 2021. Achieving end-to-end success in the clinic-Pfizer‘s learning on R&D productivity. Drug Discovery Today, 27:697, 2022 Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome ? Theoharides TC Molecular Neurobiology. 59(3):1850,2022. 本學期將有四小時生技新聞剖析 莫德納mRNA 的成長故事. Bio-NTech 的人生故事. 晟德投資重心拉回台灣. 葡萄王植物新藥向美申請二期臨床試驗.